Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Botulinum Toxin Treatment for Migraine Headache

Health Problem: Headache is a common disorder affecting more than 45 million individuals in the United States. There are several types of headache, with symptoms that vary with the underlying pathophysiology. Headaches can be primary, such as migraine, cluster, and tension headaches; or secondary to systemic, intracranial, or extracranial causes. Migraine affects 18% of women…

The Early Start Denver Model for Treatment of Autism Spectrum Disorder

Health Problem: Autism spectrum disorder (ASD) is a neurodevelopmental condition that presents in childhood and is characterized by persistent deficits in social communication and social interaction; restricted, repetitive patterns of behavior, interests, or activities; and clinically significant impairment in social, occupational, or other i…

Intrathecal Opioids for Chronic Noncancer Pain

Health Problem: Chronic pain, or pain persisting > 6 months, is a multifaceted condition with an estimated prevalence of 2% to 40% in adults in the United States. There are numerous etiologies of chronic noncancer pain. Treatment of chronic pain depends on individual and pain-related factors. Common treatments include oral analgesics, injecti…

Hybrid Maze Procedure for Atrial Fibrillation

Health Problem: Atrial fibrillation (AF) is a supraventricular, accelerated heart rhythm characterized by uncoordinated atrial activation that leads to inefficient, irregular atrial contraction. According to 2010 data, approximately 2.7 to 6.1 million people in the United States have AF. In both men and women, AF is associated with a signific…

Endolumenal Functional Lumen Imaging Probe (EndoFLIP; Medtronic Inc.) for Evaluation of Esophageal and Gastric Disorders

Health Problem: The esophageal and gastric disorders most frequently evaluated with the Endolumenal Functional Lumen Imaging Probe (EndoFLIP) are achalasia, eosinophilic esophagitis (EE), and gastroparesis, but these disorders are relatively rare, with prevalence ranging from approximately 11 to 52 cases per 100,000 persons in the general population. Disorders of esophage…

Platelet-Rich Plasma for Hip Osteoarthritis

Health Problem: Osteoarthritis (OA) is a painful condition that occurs when the cartilage between the bones degenerates, no longer providing a smooth, gliding surface for motion or adequate cushioning. Damaged articular cartilage does not tend to heal and may progressively worsen and cause focal lesions and eventually OA. Hip OA is common. The estimated lifetime risk for …

Comparative Effectiveness Review of Radioactive Yttrium-90 Microspheres for Treatment of Primary Unresectable Liver Cancer

Health Problem: Hepatocellular carcinoma (HCC) is the most common liver malignancy in the United States, accounting for approximately 90% of primary liver cancers. The definitive therapies for HCC are surgical resection, tumor ablation, and liver transplantation; however, most patients are not eligible for these therapies due to the overall burden or severity of their dis…

Comparative Effectiveness Review of Mini Gastric Bypass–One Anastomosis Gastric Bypass for the Treatment of Obesity: A Review of Reviews

Health Problem: Obesity is a common condition in the United States, where approximately 37.7% of adults aged 20 years and older are considered obese. Data from 2013 to 2014 show a rate of obesity of 17.2% among younger individuals aged 2 to 19 years. Morbid obesity is associated with substantively elevated morbidity and mortality due to comorbid conditions, including type…